Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-09-009530
Filing Date
2009-05-27
Accepted
2009-05-27 10:58:37
Documents
2
Group Members
APAX EUROPE V GP CO. LIMITED

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G u06962sc13g.htm SC 13G 46817
2 EXHIBIT A u06962exv99wa.htm EX-99.A 2956
  Complete submission text file 0000950123-09-009530.txt   51721
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 09853580
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 15 PORTLAND PLACE LONDON ENGLAND X0 W1B1PT 011442078726300
APAX PARTNERS EUROPE MANAGERS LTD (Filed by) CIK: 0001219510 (see all company filings)

EIN.: 000000000
Type: SC 13G